Search - tctmd.com

Displaying 601 - 620 of 3301

Sort: Relevancy | Date

Method to Overcome CAC Score Variability Hones Risk Stratification

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

June 26, 2023

Wintertime Brings Increased IHCA Risk, US Data Show

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

June 26, 2023

AHA Scientific Statement Addresses Health Disparities in PAD

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

June 23, 2023

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

FDA Approves Colchicine for Decreasing CV Events

News Daily News

FDA Approves Colchicine for Decreasing CV Events

June 20, 2023

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

June 16, 2023

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

June 13, 2023

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

News Daily News

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

June 08, 2023

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

May 30, 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

May 25, 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

May 25, 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

May 24, 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 12, 2023

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

News Daily News

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

May 09, 2023

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

May 05, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.